Detail page

Knowledge Web

Person

Jan Schmidt (1961-)

Chirurg

Name	Jan Schmidt
Time	1961- (Date of birth and death)
Place	Potsdam (Geburtsort) Heidelberg (Wirkungsort) Zürich (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Chirurg (characteristic profession)
Variant	J. Schmidt
Related	Klinik Hirslanden (Zürich) (2011-) Chirurgische Universitätsklinik (Heidelberg) (-Jan. 2011) Universität Heidelberg. Medizinische Fakultät (Lehrbeauftragter)
Further information	Chirurgie Heidelberg
Record type	Person
GND-Identifier	1022937995
Record ID	1022937995
Involved in show all Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560 Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial Rechtzeitige und radikale Pankreasresektion bei Vorliegen einer intraduktalen papillär-muzinösen Neoplasie – ein Fallbericht Intensivtherapie nach Transplantation solider Organe A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt Die kombinierte und sequentielle Leber-Nieren-Transplantation : Indikationen und Zentrumserfahrungen aus Sicht des Nephrologen A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma Significant Differences Between Crohn’s Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2 Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759] Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation Bedeutung der präklinischen Fehleinschätzung des Verletzungsausmaßes für die Prognose von polytraumatisierten Patienten Primäre Volumensubstitution bei experimenteller hämorrhagischer Hypotension mit hyperosmolaren und hyperonkotischen Lösungen unter besonderer Berücksichtigung der regionalen Organdurchblutung

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jan Schmidt (1961-)

Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders

Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma

Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

Rechtzeitige und radikale Pankreasresektion bei Vorliegen einer intraduktalen papillär-muzinösen Neoplasie – ein Fallbericht

Intensivtherapie nach Transplantation solider Organe

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt

Die kombinierte und sequentielle Leber-Nieren-Transplantation : Indikationen und Zentrumserfahrungen aus Sicht des Nephrologen

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Significant Differences Between Crohn’s Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients

A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation

Bedeutung der präklinischen Fehleinschätzung des Verletzungsausmaßes für die Prognose von polytraumatisierten Patienten

Primäre Volumensubstitution bei experimenteller hämorrhagischer Hypotension mit hyperosmolaren und hyperonkotischen Lösungen unter besonderer Berücksichtigung der regionalen Organdurchblutung